Filter Results:
(4,686)
Show Results For
- All HBS Web
(4,686)
- People (16)
- News (1,873)
- Research (2,258)
- Events (2)
- Multimedia (221)
- Faculty Publications (1,842)
Show Results For
- All HBS Web
(4,686)
- People (16)
- News (1,873)
- Research (2,258)
- Events (2)
- Multimedia (221)
- Faculty Publications (1,842)
- 09 Feb 2024
- HBS Case
Slim Chance: Drugs Will Reshape the Weight Loss Industry, But Habit Change Might Be Elusive
what may at first blush appear to be an easier fix: new drugs such as Ozempic, Wegovy, and Mounjaro, says Harvard Business School Professor Regina E. Herzlinger, who has studied the American health care... View Details
- Web
Publications - Institute For Strategy And Competitiveness
defining patient needs across the care cycle and mapping... November 10, 2020 Article Value-Based Health Care in Four Different View Details
- 10 Mar 2015
- News
Innovation and Implementation in Cardiovascular Medicine
- Web
Key Concepts - Institute For Strategy And Competitiveness
HBS ISC Health Care Health Care Value-Based Health View Details
- Program
Owner/President Management
long-established companies are also welcome to attend. Learning and Living at HBS OPM is a highly structured yet deeply personalized experience. From the careful selection of living group members and new HBS case studies to professional... View Details
- Article
Cybersecurity Features of Digital Medical Devices: An Analysis of FDA Product Summaries
By: Ariel Dora Stern, William J. Gordon, Adam B. Landman and Daniel B. Kramer
Objectives:
To more clearly define the landscape of digital medical devices subject to U.S. Food and Drug Administration (FDA) oversight, this analysis leverages publicly available regulatory documents to characterise the prevalence and trends of software and... View Details
To more clearly define the landscape of digital medical devices subject to U.S. Food and Drug Administration (FDA) oversight, this analysis leverages publicly available regulatory documents to characterise the prevalence and trends of software and... View Details
Keywords: Digital; Medicine; FDA; Health Care and Treatment; Applications and Software; Safety; Cybersecurity; Medical Devices and Supplies Industry
Stern, Ariel Dora, William J. Gordon, Adam B. Landman, and Daniel B. Kramer. "Cybersecurity Features of Digital Medical Devices: An Analysis of FDA Product Summaries." BMJ Open 9, no. 6 (June 2019).
- 10 Jul 2020
- News
Sutter Health’s Request to Delay $575 Million Settlement Is Denied
- February 2010 (Revised March 2012)
- Case
U.S. Healthcare Reform: International Perspectives
By: Arthur A. Daemmrich and Elia Cameron
The national economic implications of rising healthcare costs were poorly understood, even as the United States, Germany, and the United Kingdom instituted reforms in early 2010. Presenting opportunities for cross-national policy learning, this case describes the... View Details
Keywords: Macroeconomics; Insurance; Governing Rules, Regulations, and Reforms; Health Care and Treatment; Laws and Statutes; Business and Government Relations; Health Industry; Health Industry; Germany; United Kingdom; United States
Daemmrich, Arthur A., and Elia Cameron. "U.S. Healthcare Reform: International Perspectives." Harvard Business School Case 710-040, February 2010. (Revised March 2012.)
- January 2023
- Case
Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery
By: Regina Herzlinger and Brian Walker
What should a successful executive (HBS Baker Scholar) assess as her next move as the CEO of a firm with a promising and yet uncertain new drug? Amy Burroughs’ mandate to successfully commercialize Cleave Therapeutics’ drug for a cancer with no current successful... View Details
Keywords: Product Development; Leadership; Health Testing and Trials; Research and Development; Risk and Uncertainty; Financial Condition; Partners and Partnerships; Pharmaceutical Industry
Herzlinger, Regina, and Brian Walker. "Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery." Harvard Business School Case 323-045, January 2023.
- May 2009 (Revised October 2009)
- Case
Newton-Wellesley Hospital
By: Richard M.J. Bohmer and Natalie Kindred
How will Newton-Wellesley Hospital (NWH) preserve its private practice tradition while remaining effective and competitive in a healthcare industry demanding increasing integration between physicians and hospitals? This is the decision facing Newton-Wellesley Hospital... View Details
Keywords: Business Model; Profit; Health Care and Treatment; Growth and Development Strategy; Organizational Change and Adaptation; Organizational Structure; Competitive Strategy; Integration; Health Industry; Massachusetts
Bohmer, Richard M.J., and Natalie Kindred. "Newton-Wellesley Hospital." Harvard Business School Case 609-088, May 2009. (Revised October 2009.)
- 31 Mar 2020
- News
Cambridge announces COVID-19 Expert Advisory Panel
- Web
Employment Data
3% Entertainment / Media 3% Health Care 6% Investment Banking 5% Investment Management / Hedge Fund 6% Manufacturing 5% Nonprofit / Government 5% Other Financial Services 4% Private Equity 19% Retail 2%... View Details
- 02 Mar 2023
- Blog Post
Women, Work, and the "M" Word
I’m the eldest of three daughters in a medical family. With a urogynecologist and primary care doctor as parents, I grew up thinking it was normal to talk about all topics of women’s health around the dinner... View Details
When Technology Gets Ahead of Society
New technologies can be unsettling for industry incumbents, regulators, and consumers, because norms and institutions for dealing with them don't yet exist. Interestingly, businesspeople in emerging economies face similar challenges: The rules are unclear and... View Details
- September 2014
- Article
Defining the Value of Proton Therapy Using Time-Driven Activity-Based Costing
By: N.G. Thaker, A.B. Guzman, Thomas W. Feeley, T.M. Jones, J.R. Incalcaterra, C. Kolom, S.J. Frank, L.S. Tatum, Ronald S. Walters, Scott B. Cantor, D.I. Rosenthal, A.S. Garden, G.B. Gunn, C.D. Fuller and M.B. Palmer
Technological innovations in radiation therapy (RT) have rapidly improved the quality of care for patients with head and neck cancer. Intensity-modulated proton therapy (MPT) holds promise of further improving outcomes compared with the current photon-based technique... View Details
Keywords: Time-Driven Activity-Based Costing; Health Care and Treatment; Technological Innovation; Activity Based Costing and Management
Thaker, N.G., A.B. Guzman, Thomas W. Feeley, T.M. Jones, J.R. Incalcaterra, C. Kolom, S.J. Frank, L.S. Tatum, Ronald S. Walters, Scott B. Cantor, D.I. Rosenthal, A.S. Garden, G.B. Gunn, C.D. Fuller, and M.B. Palmer. "Defining the Value of Proton Therapy Using Time-Driven Activity-Based Costing." Oncology Payers, no. 1 (September 2014): 22–28.
- Program
Succeeding as a Strategic CFO
decision-making skills Review and practice applying frameworks and tools of value-based management Learn about financial policies and practices used by other organizations and determine which ones best suit your organization Formulate... View Details
- 02 Sep 2020
- News
How to Launch a New Biosciences Product: Start Small or Dive in?
- Web
Featured Topics - Faculty & Research
Featured Topics Business and Environment Business History Entrepreneurship Finance Globalization Health Care Human Behavior and Decision-Making Leadership Social Enterprise Technology and Innovation... View Details